Form 4: Amgen SVP Acquires 3,484 Shares, Boosting Holdings

Amgen's SVP of Human Resources, Derek Miller, reported the acquisition of 3,484 shares of common stock, increasing his beneficial ownership to 13,744 shares.

Summary

• Derek Miller, SVP of Human Resources at Amgen Inc., acquired 3,484 shares of Amgen common stock.
• The transaction date for this acquisition was March 3, 2026.
• The shares were acquired at a price of $0, indicating they were likely part of an equity grant or vesting event.
• Following this transaction, Mr. Miller beneficially owns a total of 13,744 shares of Amgen common stock.
• The reported shares include 176 Dividend Equivalents (DEs) granted under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan, which are credited to unvested RSUs and paid out in shares upon vesting.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as it represents an increase in insider ownership, aligning executive interests with shareholders, though it's a routine grant rather than an open market purchase.

Positives

• Increased insider ownership by a key executive, potentially signaling confidence in the company's future performance.
• The acquisition of shares, even at a $0 price (likely a grant), aligns the executive's interests with those of shareholders.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding Amgen's future financial performance or strategic direction.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as equity grants and subsequent acquisitions, are common in the biotechnology and pharmaceutical sectors, reflecting standard executive compensation practices designed to align management incentives with long-term shareholder value.

Stakeholder Impact

• Shareholders: Increased insider ownership may be perceived positively, suggesting management confidence and alignment of interests.

Key Dates

Keywords

Amgen, AMGN, Insider Transaction, Form 4, Stock Acquisition, Equity Grant, Derek Miller, Human Resources, Biotechnology